Kymera Therapeutics (KYMR) Asset Utilization Ratio (2020 - 2026)

Kymera Therapeutics (KYMR) has 7 years of Asset Utilization Ratio data on file, last reported at 0.03 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.03, down 51.41% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.03 (down 51.41% YoY), and the FY2025 annual result was 0.03, down 52.43% from the prior year.
• Asset Utilization Ratio advanced to 0.03 in Q1 2026 per KYMR's latest filing, from 0.03 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.14 in Q4 2023 and troughed at 0.03 in Q4 2025.
• A 5-year average of 0.08 and a median of 0.08 in 2022 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio soared 84.72% in 2023, then sank 66.43% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.08 in 2022, then soared by 84.72% to 0.14 in 2023, then slumped by 66.43% to 0.05 in 2024, then slumped by 41.06% to 0.03 in 2025, then increased by 9.46% to 0.03 in 2026.
• Business Quant data shows KYMR's Asset Utilization Ratio at 0.03 in Q1 2026, 0.03 in Q4 2025, and 0.04 in Q3 2025.